10-Q 1 c50807e10vq.htm FORM 1O-Q 10-Q
Table of Contents

 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 31, 2009
Commission File Number: 001-34103
SPSS Inc.
(Exact name of registrant as specified in its charter)
     
Delaware   36-2815480
(State or other jurisdiction of   (IRS Employer
incorporation or organization)   Identification No.)
233 S. Wacker Drive, Chicago, Illinois 60606
(Address of principal executive offices and zip code)
Registrant’s telephone number including area code: (312) 651-3000
     Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes þ No o
     Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes o No o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):
             
Large accelerated filer þ   Accelerated filer o   Non-accelerated filer o   Smaller reporting company o
        (Do not check if a smaller reporting company)    
     Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o No þ
     The number of shares outstanding of the registrant’s Common Stock, par value $0.01, as of April 30, 2009, was 18,326,131.
 
 

 


 

SPSS INC.
FORM 10-Q
QUARTER ENDED MARCH 31, 2009
INDEX
         
    PAGE  
       
       
    3  
    4  
    5  
    6  
    7  
    12  
    20  
    20  
 
       
       
    22  
    23  
 EX-10.1
 EX-10.2
 EX-10.3
 EX-31.1
 EX-31.2
 EX-32.1
 EX-32.2

2


Table of Contents

PART I – Financial Information
ITEM 1. Financial Statements (unaudited)
SPSS INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(In thousands, except share data)
(Unaudited)
                 
    December 31,     March 31,  
    2008     2009  
ASSETS
               
Current assets:
               
Cash and cash equivalents
  $ 305,917     $ 311,455  
Accounts receivable, net
    43,172       37,953  
Inventories, net
    433       497  
Deferred income taxes, net
    4,142       3,346  
Prepaid income taxes
    5,738       7,890  
Other current assets
    4,693       5,081  
 
           
Total current assets
    364,095       366,222  
 
           
 
               
Property, equipment and leasehold improvements, net
    14,323       13,112  
Capitalized software development costs, net
    37,470       37,517  
Goodwill
    41,845       41,459  
Intangibles, net
    2,091       1,885  
Deferred income taxes
    20,728       17,935  
Other noncurrent assets
    3,673       3,447  
 
           
Total assets
  $ 484,225     $ 481,577  
 
           
 
               
LIABILITIES AND STOCKHOLDERS’ EQUITY
               
Current liabilities:
               
Accounts payable
  $ 6,391     $ 6,908  
Income taxes and value added taxes payable
    10,877       11,452  
Deferred revenues
    83,638       78,027  
Other accrued liabilities
    22,146       17,297  
 
           
Total current liabilities
    123,052       113,684  
 
           
 
               
Long-term debt (see Note 8)
    128,106       126,631  
Noncurrent deferred income taxes, net
    8,509       7,794  
Other noncurrent liabilities
    1,937       1,857  
 
               
Stockholders’ equity:
               
Common Stock, $.01 par value; 50,000,000 shares authorized; 18,172,910 and 18,266,891 issued at December 31, 2008 and March 31, 2009, respectively
    182       183  
Additional paid-in capital (see Note 8)
    164,373       166,306  
Accumulated other comprehensive loss
    (16,197 )     (18,506 )
Retained earnings (see Note 8)
    74,263       83,628  
 
           
Total stockholders’ equity
    222,621       231,611  
 
           
Total liabilities and stockholders’ equity
  $ 484,225     $ 481,577  
 
           
See accompanying notes to consolidated financial statements.

3


Table of Contents

SPSS INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF INCOME
(In thousands, except per share data)
(Unaudited)
                 
    Three Months Ended March 31,  
    2008     2009  
Net revenues:
               
License
  $ 38,417     $ 33,770  
Maintenance
    32,147       32,495  
Services
    7,677       5,816  
 
           
 
               
Net revenues
    78,241       72,081  
 
           
 
               
Operating expenses:
               
Cost of license and maintenance revenues
    5,299       4,612  
Sales, marketing and services
    39,160       31,137  
Research and development
    11,381       10,977  
General and administrative
    8,536       8,131  
 
           
 
               
Operating expenses
    64,376       54,857  
 
           
 
               
Operating income
    13,865       17,224  
 
           
 
               
Other income (expense):
               
Interest expense (see Note 8)
    (2,440 )     (2,523 )
Interest income
    2,977       817  
Gain on convertible debt retirement
          356  
Other
    300       (1,240 )
 
           
Other income (expense)
    837       (2,590 )
 
           
 
               
Income before income taxes
    14,702       14,634  
Income tax expense
    5,664       5,269  
 
           
 
               
Net income
  $ 9,038     $ 9,365  
 
           
 
               
Basic net income per share
  $ 0.50     $ 0.51  
 
           
 
               
Diluted net income per share
  $ 0.47     $ 0.48  
 
           
 
               
Share data:
               
Shares used in computing basic net income per share
    17,916       18,233  
 
           
 
               
Shares used in computing diluted net income per share
    19,181       19,423  
 
           
See accompanying notes to consolidated financial statements.

4


Table of Contents

SPSS INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(In thousands)
(Unaudited)
                 
    Three Months Ended March 31,  
    2008     2009  
Net income
  $ 9,038     $ 9,365  
 
               
Other comprehensive income (loss):
               
Foreign currency translation adjustment
    1,961       (2,309 )
 
           
 
               
Comprehensive income
  $ 10,999     $ 7,056  
 
           
See accompanying notes to consolidated financial statements.

5


Table of Contents

SPSS INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
(Unaudited)
                 
    Three Months Ended March 31,  
    2008     2009  
Cash flows from operating activities:
               
Net income
  $ 9,038     $ 9,365  
Adjustments to reconcile net income to net cash provided by operating activities:
               
Depreciation and amortization
    4,667       4,527  
Convertible debt amortization
    1,458       1,539  
Deferred income taxes
    (109 )     2,965  
Excess tax benefit from share-based compensation
    (148 )     77  
Amortization of share-based compensation
    2,069       1,971  
Gain on convertible debt retirement
          (356 )
Changes in assets and liabilities:
               
Accounts receivable
    10,375       3,888  
Inventories
    (36 )     (67 )
Prepaid and other assets
    (1,749 )     (503 )
Accounts payable
    (310 )     650  
Accrued expenses
    (8,621 )     (4,681 )
Income taxes
    372       (1,347 )
Deferred revenue
    (1,799 )     (3,345 )
Other, net
    (1,064 )     1,160  
 
           
Net cash provided by operating activities
    14,143       15,843  
 
           
 
               
Cash flows from investing activities:
               
Capital expenditures
    (945 )     (591 )
Capitalized software development costs
    (3,099 )     (2,866 )
 
           
Net cash used in investing activities
    (4,044 )     (3,457 )
 
           
 
               
Cash flows from financing activities:
               
Proceeds from stock option exercises and employee stock purchase plan
    2,101       828  
Tax benefit from stock option exercises
    148        
Retirement of convertible debt
          (3,084 )
Purchases of common stock
    (27,870 )      
 
           
Net cash used in financing activities
    (25,621 )     (2,256 )
 
           
 
               
Effect of exchange rates on cash
    3,178       (4,592 )
 
           
Net change in cash and cash equivalents
    (12,344 )     5,538  
 
               
Cash and cash equivalents at beginning of period
    306,930       305,917  
 
           
Cash and cash equivalents at end of period
  $ 294,586     $ 311,455  
 
           
 
               
Supplemental disclosures of cash flow information:
               
Interest paid
  $ 1,888     $ 1,877  
Income taxes paid
    3,935       4,877  
Cash received from income tax refunds
    21       142  
See accompanying notes to consolidated financial statements.

6


Table of Contents

SPSS INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
NOTE 1 – Basis of Presentation
     The accompanying consolidated financial statements of SPSS Inc. (the “Company”) have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information, the instructions to United States Securities and Exchange Commission Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements. It is presumed that the reader has already read the Company’s Annual Report on Form 10-K for the year ended December 31, 2008.
     In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation have been included in these consolidated financial statements. The results of operations for the interim periods are not necessarily indicative of the results that may be expected for the fiscal year. For further information, refer to the consolidated financial statements and accompanying notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2008.
     The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. Where appropriate, some items relating to prior years have been reclassified to conform to the presentation in the current year.
NOTE 2 – Share-Based Compensation
     Share-based compensation expense, including expense related to restricted share units, under the provisions of SFAS No. 123(R) was comprised as follows (in thousands) :
                 
    Three Months Ended March 31,  
    2008     2009  
Sales, Marketing and Services
  $ 409     $ 295  
Research and Development
    280       206  
General and Administrative
    1,380       1,470  
 
           
Total share-based compensation expense
  $ 2,069     $ 1,971  
 
           

7


Table of Contents

NOTE 3 – Domestic and Foreign Operations
     Net revenues per geographic region are summarized as follows (in thousands):
                 
    Three Months Ended  
    March 31,  
    2008     2009  
United States
  $ 30,909     $ 28,502  
 
           
 
               
United Kingdom
    9,638       6,898  
The Netherlands
    10,446       8,500  
Other
    12,876       11,738  
 
           
Total Europe
    32,960       27,136  
 
           
 
               
Japan
    10,139       12,582  
Other
    4,233       3,861  
 
           
Total Pacific Rim
    14,372       16,443  
 
           
 
               
Total International
    47,332       43,579  
 
           
 
               
Net revenues
  $ 78,241     $ 72,081  
 
           
NOTE 4 – Earnings Per Common Share
     Earnings per common share (EPS) are computed by dividing net income by the weighted average number of shares of common stock (basic) plus common stock equivalents outstanding (diluted) during the period. Common stock equivalents consist of contingently issuable shares, stock options and common shares issuable on conversion of the Company’s convertible notes. The Company computes the diluted weighted average shares outstanding using the treasury stock method. Basic weighted average shares reconciles to diluted weighted average shares as follows (in thousands):
                 
    Three Months Ended
    March 31,
    2008   2009
Basic weighted average common shares outstanding
    17,916       18,233  
Dilutive effect of options and other equity
    1,265       1,190  
 
               
Diluted weighted average common shares outstanding
    19,181       19,423  
 
               
 
               
Anti-dilutive shares not included in diluted EPS calculation
    2       101  
 
               
NOTE 5 – Cost Management Programs
     During 2007, the Company incurred expenses totaling $4.6 million related to a management reorganization and a planned consolidation of certain research and development facilities. These costs principally included employee severance costs, lease exit costs and the write-off of leasehold improvements. These costs are primarily recorded as a component of Research and Development expense in the Consolidated Statements of Income. As of March 31, 2009, the Company has remaining approximately $0.8 million in other accrued liabilities and $0.2 million in other noncurrent liabilities related to these expenses and expects the liabilities to be paid in 2009.

8


Table of Contents

     During 2008, the Company incurred expenses totaling $4.8 million related to a cost management program involving staff reorganization and reduction. These costs primarily included employee severance costs and are primarily recorded as a component of Sales, Marketing and Services expense in the Consolidated Statements of Income. As of March 31, 2009, the Company has remaining approximately $0.1 million in other accrued liabilities related to these expenses and expects the liabilities to be paid in 2009.
NOTE 6 – Recent Accounting Pronouncements
     In September 2006, the FASB issued SFAS No. 157, “Fair Value Measurements,” which defines fair value, establishes a framework for measuring fair value in generally accepted accounting principles, and expands disclosures about fair value measurements. SFAS No. 157 does not require any new fair value measurements, but provides guidance on how to measure fair value by providing a fair value hierarchy used to classify the source of the information. This statement is effective for fiscal years beginning after November 15, 2007. On February 14, 2008 the FASB issued FSP FAS No. 157-1 “Application of FASB Statement No. 157 to FASB Statement 13 and Other Accounting Pronouncements That Address Fair Value Measurements for Purposes of Lease Classification or Measurement Under Statement 13” that amends SFAS No. 157 to exclude its application for purposes of lease classification or measurement under SFAS13. On February 12, 2008, the FASB issued Staff Position Financial Accounting Standard (FSP FAS) No. 157-2 “Effective Date of FASB Statement No. 157” that amends SFAS No. 157 to delay the effective date for all non-financial assets and non-financial liabilities, except those that are recognized or disclosed at fair value in the financial statements on a recurring basis to fiscal years beginning after November 15, 2008. The Company adopted the required provisions of SFAS No. 157-1 effective January 1, 2008 and there was no material effect on its consolidated financial statements. On January 1, 2009, the Company adopted FSP 157-2 and it did not have a material impact on its consolidated financial statements.  In October 2008, the FASB issued FSP 157-3, “Determining the Fair Value of a Financial Asset in a Market That Is Not Active.” The FSP was effective upon issuance, including periods for which financial statements have not been issued. The FSP clarified the application of SFAS 157 in an inactive market and provided an illustrative example to demonstrate how the fair value of a financial asset is determined when the market for that financial asset is inactive. The adoption of this FSP FAS 157-3 did not have a material impact on the Company’s consolidated financial statements.
     In April 2008, the FASB issued FASB Staff Position No. FAS 142-3, Determination of the Useful Life of Intangible Assets (“FSP No. FAS 142-3”). FSP No. FAS 142-3 requires companies estimating the useful life of a recognized intangible asset to consider their historical experience in renewing or extending similar arrangements or, in the absence of historical experience, to consider assumptions that market participants would use about renewal or extension as adjusted for SFAS No. 142’s, Goodwill and Other Intangible Assets, entity-specific factors.  FSP No. FAS 142-3 is effective for fiscal years beginning after December 15, 2008.  The Company adopted FSP No. FAS 142-3 on January 1, 2009.  The adoption of FSP No. FAS 142-3 did not have a material effect on its consolidated financial statements.
     In May 2008, the FASB issued Statement of Financial Accounting Standards (“SFAS”) No. 162, “The Hierarchy of Generally Accepted Accounting Principles.”  SFAS No. 162 identifies the sources of accounting principles and the framework for selecting the principles used in the preparation of financial statements that are presented in conformity with generally accepted accounting principles.  SFAS No. 162 becomes effective 60 days following the SEC’s approval of the Public Company Accounting Oversight Board amendments to AU Section 411, “The Meaning of Present Fairly in Conformity With Generally Accepted Accounting Principles.”  The Company does not expect that the adoption of SFAS No. 162 to have a material effect on its consolidated financial statements.
     On January 1, 2009, the Company adopted FASB No. 141 (Revised 2007), “Business Combinations” (“FAS No. 141(R)”).  FAS No. 141(R) significantly changed the accounting for business combinations. Under FAS No. 141(R), an acquiring entity is required to recognize all the assets acquired and all the liabilities assumed in a transaction at the acquisition-date fair value with limited exceptions. Transaction costs are no longer included in the measurement of the business acquired. Instead, these costs are expensed as they are incurred. FAS No. 141(R) also includes a substantial number of new disclosure requirements. FAS No. 141(R) applies to business combinations for which the acquisition date is on or after the beginning of the first annual reporting period beginning on or after December 15, 2008. The adoption of FAS No. 141(R) did not have a material impact on the Company’s consolidated financial statements.

9


Table of Contents

NOTE 7 – Contingencies
     Basu Litigation
     SPSS Inc. has been named as a defendant in a lawsuit filed on December 6, 2002 in the United States District Court for the Southern District of New York, under the caption Basu v. SPSS Inc., et al., Case No. 02CV9694. The complaint alleges that, in connection with the issuance and initial public offering of shares of common stock of NetGenesis Corp., the registration statement and prospectus filed with the Securities and Exchange Commission in connection with the IPO contained material misrepresentations and/or omissions. The alleged violations of the federal securities laws took place prior to December 31, 2001, the effective date of the merger in which the Company’s acquisition subsidiary merged with and into NetGenesis Corp. NetGenesis Corp. is now a wholly owned subsidiary of SPSS. Other defendants to this action include the former officers and directors of NetGenesis Corp. and the investment banking firms that acted as underwriters in connection with the IPO. The plaintiff is seeking unspecified compensatory damages, prejudgment and post-judgment interest, reasonable attorney fees, experts’ witness fees and other costs and any other relief deemed proper by the Court. The Company is aggressively defending itself, and plans to continue to aggressively defend itself against the claims set forth in the complaint. The Company and the named officers and directors filed an answer to the complaint on July 14, 2003. At this time, the Company believes the lawsuit will be settled with no material adverse effect on its results of operations, financial condition, or cash flows.
     Trademark Litigation
     On January 3, 2008, the Company filed a complaint for declaratory judgment in the U.S. District Court for the Northern District of Illinois against Norman H. Nie and C. Hadlai Hull. The filing of the complaint was in response to recent assertions by Dr. Nie that the Company’s use of the SPSS trademark was subject to a License Agreement (the “Agreement”) dated September 30, 1976 between a predecessor of the Company, as licensee, and Norman H. Nie and C. Hadlai Hull, as licensors. Dr. Nie stated his desire to enforce his alleged rights under the Agreement, which he claimed included the right to inspect and approve products sold under the SPSS trademark and to obtain other information regarding those products. The complaint seeks a declaratory judgment that Dr. Nie and Mr. Hull are estopped from enforcing any rights under the Agreement and that the Company shall be deemed to have an irrevocable, assignable and exclusive license to use the SPSS trademark.
     On January 28, 2008, Dr. Nie and Mr. Hull filed a counterclaim against the Company. The counterclaim asserts that the Company has repudiated the Agreement and that the Company’s use of the SPSS trademark is unauthorized and constitutes an infringement on their rights as owners of the trademark. The counterclaim seeks an injunction prohibiting the Company from continuing to use the SPSS trademark and an award of damages, costs and attorneys fees.
     On February 15, 2008, the Company filed its answer to the counterclaim. In its answer, the Company denies liability for trademark infringement and asserts that Dr. Nie and Mr. Hull are barred from asserting the counterclaim on several grounds, including but not limited to the doctrines of estoppel, laches and waiver.
     In May 2008, Dr. Nie filed an amended counterclaim to reflect that Mr. Hull had subsequently assigned his claims to Dr. Nie. Discovery has been completed. Each of the Company and Dr. Nie filed motions for summary judgment. Each motion for summary judgment was denied by the Court on April 2, 2009. The Court has set October 5, 2009 as the trial date.
     On April 27, 2009, Dr. Nie filed a complaint against the Company in the Court of Chancery of the State of Delaware seeking the advancement of legal fees and expenses incurred by Dr. Nie in connection with the action described above. The complaint seeks a declaration that SPSS must pay all such legal fees and expenses (both fees incurred to date and any fees to be incurred in the future), the payment of interest on all legal fees and expenses incurred by Dr. Nie to date and all legal fees and expenses incurred in connection with this action in Delaware.
NOTE 8 – Implementation of FASB Staff Position No. APB 14-1
     The Company adopted the provisions of FASB Staff Position No. APB 14-1 (“FSP” or “FSP No. APB 14-1”), “Accounting for Convertible Debt Instruments That May Be Settled in Cash upon Conversion (Including Partial Cash Settlement)” on January 1, 2009.  FSP No. APB 14-1 requires that issuers of convertible debt instruments that may be settled in cash upon conversion separately account for the liability and equity components in a manner that will reflect the entity’s nonconvertible debt borrowing rate when interest cost is recognized in subsequent periods.

10


Table of Contents

     The FSP requires retrospective application related to the Company’s convertible debt that was outstanding during the periods presented in the financial statements. As the Company issued its convertible bonds on March 19, 2007, the Company applied FSP No. APB 14-1 retrospectively to 2008 including the following effects on the Company’s income statement captions for the three months ended March 31, 2008:
                         
    Three Months Ended March 31, 2008
    (In thousands, except per share data)
            Effect of Change    
    As originally   in Accounting    
    reported   Principle   As adjusted
Interest expense
  $ 1,157     $ 1,283     $ 2,440  
Net income
  $ 9,830     $ (792 )   $ 9,038  
 
                       
Diluted earnings per share
  $ 0.51     $ (0.04 )   $ 0.47  
     The FSP also requires recognition of the cumulative effect of this accounting change to be recognized as of the beginning of the first period presented. This cumulative effect of adopting FSP No. APB 14-1 resulted in the following changes to the Company’s December 31, 2008 balance sheet:
    decrease to convertible debt of $21.9 million;
 
    increase to additional paid-in capital of $17.3 million;
 
    increase to non-current deferred tax liability of $7.5 million;
 
    decrease to other assets of $2.8 million; and
 
    decrease of $5.7 million to retained earnings for the cumulative net income effect of adopting the FSP.
     Additional details related to the Company’s adoption of FSP No. APB 14-1 include the following:
                 
    Three Months Ended March 31,  
    2008     2009  
    (In thousands, except percentage data)
Interest expense — Contractual interest coupon
  $ 939     $ 939  
Interest expense — Debt discount amortization
    1,283       1,365  
Interest expense — Debt issuance cost amortization
    218       219  
 
           
Total interest expense
  $ 2,440     $ 2,523  
 
           
 
               
Effective interest rate on the liability component
    7.2 %     7.2 %
         
    As of March 31, 2009  
    ($ in thousands)  
Net carrying amount of liability component
  $ 126,631  
Unamortized transaction costs with third parties allocated to liability
    1,985  
Unamortized discount of liability component
    17,884  
 
     
Principal amount of the liability component
  $ 146,500  
 
     
 
       
Net carrying amount of equity component
  $ 17,077  
 
     
 
       
Remaining amortization period of discount of liability component
  2.96 Years  
     The 2.50% Convertible Subordinated Notes due 2012 (the “Convertible Notes”) will be convertible into cash and, if applicable, shares of the Company’s common stock, par value $0.01 per share (the “Common Stock”) based on an initial conversion rate of

11


Table of Contents

21.3105 shares of Common Stock per $1,000 principal amount of Convertible Notes (which is equal to an initial conversion price of approximately $46.93 per share) upon the occurrence of certain events.
NOTE 9 – Convertible Notes Repurchase
     On March 11, 2009, the Company announced that its Board of Directors had authorized the Company to repurchase up to a maximum of $40 million of its issued and outstanding 2.50% Convertible Subordinated Notes due 2012 (the “Convertible Notes”). These repurchases are not mandatory and will be made from time to time based on the availability of alternative investment opportunities and market conditions. This authorization expires on December 31, 2009. On March 20, 2009, the Company repurchased $3.5 million principal amount of the Convertible Notes at a cost of $3.1 million. The Company recognized a gain of $0.4 million related to this Convertible Note repurchase reflected in the line caption “Gain on convertible debt retirement” in the consolidated statements of income. Following this repurchase, $36.9 million remains available under the authorization and $146.5 million principal amount of the Convertible Notes remain outstanding.
ITEM 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
In addition to historical information, this quarterly report on form 10-Q contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934, including, without limitation, statements regarding the Company’s expectations, beliefs, intentions or future strategies that are signified by the words “expects,” “anticipates,” “intends,” “believes,” “estimates” or similar language. All forward-looking statements included in this document are based on information available to the Company on the date hereof. The Company cautions investors that its business and financial performance and the matters described in these forward-looking statements are subject to substantial risks and uncertainties. Because of these risks and uncertainties, some of which may not be currently ascertainable and many of which are beyond the Company’s control, actual results could differ materially from those expressed in or implied by the forward-looking statements. The potential risks and uncertainties that could cause results to differ materially include, but are not limited to: the Company’s ability to predict revenue, the Company’s ability to respond to rapid technological changes, a potential loss of relationships with third parties from whom the Company licenses certain software, fluctuations in currency exchange rates, the impact of new accounting pronouncements, increased competition and risks associated with product performance and market acceptance of new products. A detailed discussion of these and other risk factors that affect the Company’s business is contained in the Company’s annual reports on form 10-K, particularly under the heading “Risk Factors.” The Company does not intend to update these forward-looking statements to reflect actual future events.
The following discussion should be read in conjunction with the Company’s financial statements and accompanying notes, which appear elsewhere in this Quarterly Report on Form 10-Q.
COMPARISON OF THREE MONTHS ENDED MARCH 31, 2008 TO THREE MONTHS ENDED MARCH 31, 2009.
NET REVENUE
     Revenues by product category, related amount changes, related percent changes and percent of total revenues for the three months ended March 31, 2008 and three months ended March 31, 2009 were as follows:
                                                 
    Three Months Ended                    
    March 31,     March 31,     Amount     Percentage     Percent of Net Revenues  
    2008     2009     Change     Change     2008     2009  
    (In thousands)                                  
License
  $ 38,417     $ 33,770     $ (4,647 )     (12 )%     49 %     47 %
Maintenance
    32,147       32,495       348       1 %     41 %     45 %
Services
    7,677       5,816       (1,861 )     (24 )%     10 %     8 %
 
                                   
Net revenues
  $ 78,241     $ 72,081     $ (6,160 )     (8 )%     100 %     100 %
 
                                   
     Foreign currency exchange rates decreased net revenues by $5.3 million from the three months ended March 31, 2008 to the three months ended March 31, 2009. Excluding currency, revenues declined $0.8 million, or 1%, from the three months ended March 31,

12


Table of Contents

2008 to the three months ended March 31, 2009 resulting from lower license revenue and service revenue partially offset by higher maintenance revenue as further explained in the related revenue captions below.
     License revenue
                                 
    Three Months Ended              
    March 31,     March 31,     Amount     Percentage  
    2008     2009     Change     Change  
    (In thousands)                  
United States
  $ 16,571     $ 13,090     $ (3,481 )     (21 )%
Europe
    12,106       9,155       (2,951 )     (24 )%
Pacific Rim
    9,740       11,525       1,785       18 %
 
                       
Net license revenues
  $ 38,417     $ 33,770     $ (4,647 )     (12 )%
 
                       
     The overall decrease in license revenues from the three months ended March 31, 2008 to the three months ended March 31, 2009 was primarily due to the following:
    lower sales volume of desktop statistical tools and data mining tools of $2.1 million
 
    lower market research product revenue of $1.4 million
The decrease in revenue in the three months ended March 31, 2009 was generally due to lower sales volume for deals individually exceeding $75,000 in Europe, the impact of foreign currency exchange rates, lower demand in the United States and a more challenging economic environment in 2009. For the three months ended March 31, 2008, the Company closed 39 deals in Europe individually exceeding $75,000 and totaling $6.7 million compared with 31 deals individually exceeding $75,000 and totaling $4.9 million for the three months ended March 31, 2009. The decrease in revenue in the United States was primarily due to sales staff turnover and lower demand due to a more challenging economic environment.
Foreign currency exchange rates decreased license revenue by $2.1 million in Europe, most notably $0.8 million in the United Kingdom and $0.6 million in the Netherlands.
The revenue decreases in the United States and Europe were partially offset by higher revenue in the Pacific Rim. Revenues increased $1.8 million in the Pacific Rim principally due to higher revenues in Japan due to foreign currency of $1.0 million and higher sales volume of statistical tools of $0.9 million
     Maintenance revenue
                                 
    Three Months Ended              
    March 31,     March 31,     Amount     Percentage  
    2008     2009     Change     Change  
    (In thousands)                  
United States
  $ 11,113     $ 12,971     $ 1,858       17 %
Europe
    17,118       15,519       (1,599 )     (9 )%
Pacific Rim
    3,916       4,005       89       2 %
 
                       
Net maintenance revenues
  $ 32,147     $ 32,495     $ 348       1 %
 
                       
     The overall increase in maintenance revenues from the three months ended March 31, 2008 to the three months ended March 31, 2009 was primarily due to continued strong demand for the Company’s maintenance support and product upgrades as well as higher renewal rates by the Company’s customer base across all major geographic regions (most notable in the desktop statistical tools and data mining product categories). These strong renewal rates were offset by changes in foreign currency exchange rates which decreased maintenance revenue by $3.2 million including $3.1 million in Europe.

13


Table of Contents

Service revenue
                                 
    Three Months Ended              
    March 31,     March 31,     Amount     Percentage  
    2008     2009     Change     Change  
    (In thousands)                  
United States
  $ 3,225     $ 2,441     $ (784 )     (24 )%
Europe
    3,736       2,462       (1,274 )     (34 )%
Pacific Rim
    716       913       197       28 %
 
                       
Net service revenues
  $ 7,677     $ 5,816     $ (1,861 )     (24 )%
 
                       
     Service revenues decreased from the three months ended March 31, 2008 to the three months ended March 31, 2009 primarily due to a decline in consulting projects as a result of lower license revenue. Additionally, changes in foreign currency rates decreased service revenues in Europe by $0.7 million for the three month period ended March 31, 2009 including $0.4 million in the United Kingdom.
     Net revenues per geographic region, percentage changes and percent of total revenues for the three month period ended March 31, 2009 was as follows:
                                                 
    Three Months Ended                    
    March 31,     March 31,     Amount     Percentage     Percent of Net Revenues  
    2008     2009     Change     Change     2008     2009  
    (In thousands)                                  
United States
  $ 30,909     $ 28,502     $ (2,407 )     (8 )%     40 %     40 %
 
                                   
 
                                               
United Kingdom
    9,638       6,898       (2,740 )     (28 )%     12 %     9 %
The Netherlands
    10,446       8,500       (1,946 )     (19 )%     13 %     12 %
Other
    12,876       11,738       (1,138 )     (9 )%     17 %     16 %
 
                                   
Total Europe
    32,960       27,136       (5,824 )     (18 )%     42 %     37 %
 
                                   
 
                                               
Japan
    10,139       12,582       2,443       24 %     13 %     18 %
Other
    4,233       3,861       (372 )     (9 )%     5 %     5 %
 
                                   
Total Pacific Rim
    14,372       16,443       2,071       14 %     18 %     23 %
 
                                   
 
                                               
Total International
    47,332       43,579       (3,753 )     (8 )%     60 %     60 %
 
                                   
 
                                               
Net revenues
  $ 78,241     $ 72,081     $ (6,160 )     (8 )%     100 %     100 %
 
                                   
     Net revenues derived internationally decreased 8% from the three month period ended March 31, 2008 to the three month period ended March 31, 2009. This decrease resulted from a revenue decline in almost all significant international markets throughout Europe including the United Kingdom, the Netherlands, France and Sweden partially offset by increases in Japan. These decreases reflected the impact of foreign currency exchange rates as well as declining demand for the Company’s desktop statistical and data mining tools and market research products. In particular, from the three months ended March 31, 2008 to the three months ended March 31, 2009, revenues declined in the United Kingdom by $2.7 million, or 28%, primarily reflecting the impact of changes in foreign currency exchange rates of $2.6 million and lower service revenue of $0.2 million. Additionally, revenues in the Netherlands declined by $1.9 million, or 19%, primarily reflecting the impact of changes in foreign currency exchange rates of $1.3 million and lower license revenues of $0.8 million. Net revenues derived in the United States decreased by 8% reflecting a decline in revenue from desktop statistical tools, data mining tools and market research products offset by growth in maintenance revenue.
     Changes in foreign currency exchange rates were a significant factor and decreased international revenue from the three months ended March 31, 2008 to the three months ended March 31, 2009 as follows:

14


Table of Contents

         
    Three months ended  
    March 31,  
    2009  
Country (Currency)   (In thousands)  
Netherlands (Euro)
  $ (1,344 )
Other Euro-denominated countries
    (1,337 )
United Kingdom (Pound)
    (2,633 )
Japan (Yen)
    1,287  
Other currencies
    (1,303 )
 
     
Total
  $ (5,330 )
 
     
COST OF LICENSE AND MAINTENANCE REVENUES
                                                 
    Three Months Ended            
    March 31,   March 31,   Amount   Percentage   Percent of Net Revenues
    2008   2009   Change   Change   2008   2009
    (In thousands)                                
Three months ended March 31,
  $ 5,299     $ 4,612     $ (687 )     (13 )%     7 %     6 %
     Cost of license and maintenance revenues consists of costs of goods sold, amortization of capitalized software development costs and royalties paid to third parties. These costs decreased from the three month period ended March 31, 2008 to the three month period ended March 31, 2009 primarily due to a $0.4 million decrease in product material and delivery costs and a $0.1 million decrease in royalties paid to third parties as a result of lower license revenues. The Company expects the cost of license and maintenance revenues to remain relatively constant as a percentage of total revenues at approximately 6% for the remainder of 2009.
SALES, MARKETING AND SERVICES
                                                 
    Three Months Ended            
    March 31,   March 31,   Amount   Percentage   Percent of Net Revenues
    2008   2009   Change   Change   2008   2009
    (In thousands)                                
Three months ended March 31,
  $ 39,160     $ 31,137     $ (8,023 )     (20 )%     50 %     43 %
     Sales, marketing and services expenses decreased from the three month period ended March 31, 2008 to the three month period ended March 31, 2009 primarily due to decreased compensation costs associated with lower revenues, lower travel and entertainment expenditures and $1.6 million lower salaries resulting from the Company’s cost management initiatives implemented in the fourth quarter of 2008. Changes in foreign currency exchange rates contributed $3.0 million to the decrease in the three month period ended March 31, 2009. The Company expects sales, marketing and services costs to be approximately 45% of net revenues for the remainder of 2009.
RESEARCH AND DEVELOPMENT
                                                 
    Three Months Ended            
    March 31,   March 31,   Amount   Percentage   Percent of Net Revenues
    2008   2009   Change   Change   2008   2009
    (In thousands)                                
Three months ended March 31,
  $ 11,381     $ 10,977     $ (404 )     (4 )%     15 %     15 %
     Research and development costs decreased from the three month period ended March 31, 2008 to the three month period ended March 31, 2009 primarily due to decreased project related expenses, improved productivity and $0.7 million in lower salaries resulting from the Company’s cost management initiatives implemented in the fourth quarter of 2008. The Company expects the research and development costs to remain relatively constant as a percentage of total revenues at 15% for the remainder of 2009.

15


Table of Contents

GENERAL AND ADMINISTRATIVE
                                                 
    Three Months Ended            
    March 31,   March 31,   Amount   Percentage   Percent of Net Revenues
    2008   2009   Change   Change   2008   2009
    (In thousands)                                
Three months ended March 31,
  $ 8,536     $ 8,131     $ (405 )     (5 )%     10 %     12 %
     General and administrative expenses decreased from the three month period ended March 31, 2008 to the three month period ended March 31, 2009 primarily due to lower travel and entertainment and lower salary expense associated with the Company’s cost management initiatives implemented in the fourth quarter of 2008.
OPERATING INCOME
                                                 
    Three Months Ended            
    March 31,   March 31,   Amount   Percentage   Percent of Net Revenues
    2008   2009   Change   Change   2008   2009
    (In thousands)                                
Three months ended March 31,
  $ 13,865     $ 17,224     $ 3,359       24 %     18 %     24 %
     Operating income increased from the three month period ended March 31, 2008 to the three month period ended March 31, 2009 primarily due to decreases in operating expenses in excess of the decrease in net revenues. Decreased operating expenses primarily resulted from lower cost of sales and lower selling expenses associated with the Company’s cost management initiatives described in Note 5. See further discussion of these expenses under the caption heading above.
INTEREST EXPENSE
                                                 
    Three Months Ended            
    March 31,   March 31,   Amount   Percentage   Percent of Net Revenues
    2008   2009   Change   Change   2008   2009
    (In thousands)                                
Three months ended March 31,
  $ 2,440     $ 2,523     $ 83       3 %     3 %     4 %
     Interest expense consists of cash interest computed at the 2.50% coupon rate on the Company’s Convertible Subordinated Notes due 2012 and amortization of debt discount determined using the effective interest method. The increase in interest expense from the three month period ended March 31, 2008 to the three month period ended March 31, 2009 was primarily due to the interest accretion on the additional debt discount amortization. See additional discussion in Note 8 to the Consolidated Financial Statements.
INTEREST INCOME
                                                 
    Three Months Ended            
    March 31,   March 31,   Amount   Percentage   Percent of Net Revenues
    2008   2009   Change   Change   2008   2009
    (In thousands)                                
Three months ended March 31,
  $ 2,977     $ 817     $ (2,160 )     (73 )%     4 %     1 %
     Interest income decreased from the three month period ended March 31, 2008 to the three month period ended March 31, 2009 primarily due to lower interest rates on investment cash balances.
GAIN ON CONVERTIBLE DEBT RETIREMENT
                                                 
    Three Months Ended            
    March 31,   March 31,   Amount   Percentage   Percent of Net Revenues
    2008   2009   Change   Change   2008   2009
    (In thousands)                                
Three months ended March 31,
  $     $ 356     $ 356     NM     %     %

16


Table of Contents

     On March 11, 2009, the Company announced that its Board of Directors had authorized the Company to repurchase up to a maximum of $40 million of its issued and outstanding 2.50% Convertible Subordinated Notes due 2012 (the “Convertible Notes”). During the three month period ended March 31, 2009, the Company repurchased $3.5 million principal amount of the Convertible Notes at a cost of $3.1 million resulting in a gain of $0.4 million.
OTHER INCOME (EXPENSE)
                                                 
    Three Months Ended            
    March 31,   March 31,   Amount   Percentage   Percent of Net Revenues
    2008   2009   Change   Change   2008   2009
    (In thousands)                                
Three months ended March 31,
  $ 300     $ (1,240 )   $ (1,540 )   NM     %     (1 )%
     Other income (expense) changed from income for the three month period ended March 31, 2008 to expense for the three month period ended March 31, 2009 primarily due to transactional losses in 2009 resulting from changes in the value of Singapore dollar denominated receivables/payables, U.S. dollar denominated cash held in foreign countries and the decrease in value of U.S. dollar-denominated receivables held in international locations, principally related to the Euro and the British Pound.
INCOME TAX EXPENSE
                                                 
    Three Months Ended            
    March 31,   March 31,   Amount   Percentage   Percent of Pre-Tax Income
    2008   2009   Change   Change   2008   2009
    (In thousands)                                
Three months ended March 31,
  $ 5,664     $ 5,269     $ (395 )     (7 )%     38.5 %     36.0 %
     The income tax provision decreased from the three month period ended March 31, 2008 to the three month period ended March 31, 2009 principally reflecting higher research and development tax credits in 2009. Generally, the Company expects its full year effective tax rate to be 33% to 36% given the current geographic income mix.
LIQUIDITY AND CAPITAL RESOURCES
     During the three month period ended March 31, 2009, SPSS generated cash in excess of its operating requirements. As of March 31, 2009, SPSS had $311.5 million in cash and cash equivalents compared with $305.9 million at December 31, 2008. The increase in cash principally resulted from cash generated from operating activities. Factors affecting cash and cash equivalents during the three month period ended March 31, 2009 include:
          Operating Cash Flows:
    Cash derived from operating activities was $15.8 million. This cash resulted primarily from net income and receivable collections, partially offset by accrued expenses.
 
    Accounts receivable increased operating cash flow by $3.9 million reflecting favorable collections. Average days sales outstanding were 48 days at March 31, 2009, compared to 54 days at December 31, 2008 and 57 days at March 31, 2008.
 
    Accrued expenses decreased operating cash flow by $4.7 million and generally reflected payment of accrued severance related to the Company’s fourth quarter 2008 cost management initiative program.
         Investing Activities:
    Capital expenditures were $0.6 million.
 
    Capitalized software development costs were $2.9 million.

17


Table of Contents

          Financing Activities:
    The Company utilized $3.1 million to repurchase the Company’s 2.50% Convertible Subordinated Notes due 2012.
 
    Cash proceeds of $0.8 million received from the issuance of common stock, primarily through the employee stock purchase plan.
     Cash flows from operating activities were more than adequate to fund capital expenditures and software development costs of $3.5 million. Management believes that cash flows from future operating activities will be more than adequate to meet future capital expenditures and software development costs.
     On March 19, 2007, the Company issued $150 million aggregate principal amount of 2.50% Convertible Subordinated Notes due 2012 (the “Convertible Notes”) in a private placement.
     The Convertible Notes will be convertible into cash and, if applicable, shares of the Company’s common stock, par value $0.01 per share (the “Common Stock”) based on an initial conversion rate of 21.3105 shares of Common Stock per $1,000 principal amount of Convertible Notes (which is equal to an initial conversion price of approximately $46.93 per share) only under the following circumstances: (1) during any calendar quarter (and only during such calendar quarter), if the closing sale price of the Common Stock for at least 20 trading days in the 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is more than 120% of the conversion price per share, which is $1,000 divided by the then applicable conversion rate; (2) during any five business day period after any five consecutive trading day period in which the trading price per $1,000 principal amount of Convertible Notes for each day of that period was less than 98% of the product of the closing price of the Common Stock for each day in that period and the conversion rate; (3) if specified distributions to holders of the Common Stock occur; (4) if a fundamental change occurs; or (5) during the period beginning on February 15, 2012 and ending on the close of business on the business day immediately preceding the maturity date. If the Company makes a physical settlement election as described below, the Convertible Notes will become convertible at the option of the holder at any time after the date of such physical settlement election and prior to the close of business on the business day immediately preceding the maturity date of the Convertible Notes.
     Unless the Company has made a physical settlement election, upon conversion of each $1,000 principal amount of Convertible Notes, a holder will receive, in lieu of Common Stock, an amount in cash equal to the lesser of (i) $1,000, or (ii) the conversion value of the Convertible Notes. If the conversion value exceeds $1,000 on the conversion date, the Company will also deliver as payment for the excess value, at its election, cash or Common Stock or a combination of cash and Common Stock. At any time prior to maturity, the Company may make a physical settlement election. A physical settlement election is the irrevocable election to provide upon conversion, in lieu of providing cash and Common Stock, shares of Common Stock equal to the conversion rate for each $1,000 principal amount of Convertible Notes converted.
     On March 11, 2009, the Company announced that its Board of Directors had authorized the Company to repurchase up to a maximum of $40 million of its issued and outstanding Convertible Notes. These repurchases are not mandatory and will be made from time to time based on the availability of alternative investment opportunities and market conditions. This authorization expires on December 31, 2009. On March 20, 2009, the Company repurchased $3.5 million principal amount of the Convertible Notes at a cost of $3.1 million. Following this repurchase, $36.9 million remains available under the authorization and $146.5 million principal amount of the Convertible Notes remain outstanding.
     As of March 31, 2009, the Convertible Notes were not convertible and the holders of the Convertible Notes had no right to require the Company to repurchase the Convertible Notes.
     On March 27, 2008, the Company entered into a three-year senior revolving credit facility (the “Credit Facility”) that enables the Company to borrow up to $50 million.  The Credit Facility was entered into between the Company and LaSalle Bank National Association, now known as Bank of America, as lender (the “Lender”).  Borrowings under the Credit Facility may be borrowed by the Company (or one or more subsidiaries designated by the Company) in U.S. dollars, Australian dollars, Euros, Pounds Sterling, Japanese Yen and in other currencies that the Lender may approve from time to time.  Borrowings under the Credit Facility will bear interest at a rate per annum equal to the applicable eurocurrency rate plus a 0.50% spread.  The Company will pay a fee of 0.10% of the unused amount of the Credit Facility.  The Company has guaranteed the obligations of all subsidiary borrowers under the Credit Facility. As of March 31, 2009, the Company had not borrowed any funds under this credit facility.

18


Table of Contents

     Borrowings under the Credit Facility are subject to the Company’s satisfaction of various conditions at the time of borrowing. The Credit Facility contains the following financial covenants:
    the Company is required to have consolidated EBITDA of at least $40,000,000 for each period of four consecutive fiscal quarters; and
 
    the Company is required to maintain a ratio of (a) (x) consolidated total debt less (y) cash and cash equivalents to (b) consolidated EBITDA of not greater than 2.50 to 1, with compliance with such covenant to be tested on the last day of each fiscal quarter.
     The Credit Facility contains other customary covenants, including restrictions on liens, asset sales, acquisitions and debt permitted to be incurred by subsidiaries, and events of default.  The remedies for events of default are customary for this type of credit facility. The Company was in compliance with all conditions and covenants as of March 31, 2009.
     SPSS intends to fund its future capital needs through operating cash flows and cash and cash equivalents on hand. SPSS anticipates that these amounts will be sufficient to fund the Company’s operations and capital requirements at the current level of operations. However, no assurance can be given that changing business circumstances will not require additional capital for reasons that are not currently anticipated or that the necessary additional capital will then be available to SPSS on favorable terms or at all.
     The Company’s cash and cash equivalents of $311.5 million as of March 31, 2009, were comprised of highly liquid investments with original maturity dates of three months or less. The Company places temporary cash investments with top-tier institutions of high credit quality. Additionally, the money market funds in which the Company invests are participants in the United States Treasury Department’s Temporary Guarantee Program for Money Market Funds. This program provides coverage for amounts held in money market funds as of the close of business on September 19, 2008. The program is designed to address temporary dislocations in credit markets. On March 31, 2009, the United States Treasury Department extended this program through September 18, 2009. As of March 31, 2009, the Company had $171.3 million of cash investments covered under the aforementioned program. Also, an additional $79.5 million of the Company’s cash and cash equivalents was covered by certain international government insurance programs.
CRITICAL ACCOUNTING POLICIES
     The Company’s consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States of America. As such, SPSS makes certain estimates, judgments and assumptions that it believes are reasonable based upon the information available. These estimates and assumptions affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the periods presented. The Company’s critical accounting policies include revenue recognition, capitalization of software development costs, impairment of long-lived assets, impairment of goodwill and intangible assets, the estimation of credit losses on accounts receivable and the valuation of deferred tax assets. For a discussion of these critical accounting policies, see “Critical Accounting Policies and Estimates” in the SPSS Annual Report on Form 10-K for the year ended December 31, 2008, filed with the Securities and Exchange Commission on February 18, 2009.
RECENT ACCOUNTING PRONOUNCEMENTS
     In September 2006, the FASB issued SFAS No. 157, “Fair Value Measurements,” which defines fair value, establishes a framework for measuring fair value in generally accepted accounting principles, and expands disclosures about fair value measurements. SFAS No. 157 does not require any new fair value measurements, but provides guidance on how to measure fair value by providing a fair value hierarchy used to classify the source of the information. This statement is effective for fiscal years beginning after November 15, 2007. On February 14, 2008 the FASB issued FSP FAS No. 157-1 “Application of FASB Statement No. 157 to FASB Statement 13 and Other Accounting Pronouncements That Address Fair Value Measurements for Purposes of Lease Classification or Measurement Under Statement 13” that amends SFAS No. 157 to exclude its application for purposes of lease classification or measurement under SFAS13. On February 12, 2008, the FASB issued Staff Position Financial Accounting Standard (FSP FAS) No. 157-2 “Effective Date of FASB Statement No. 157” that amends SFAS No. 157 to delay the effective date for all non-financial assets and non-financial liabilities, except those that are recognized or disclosed at fair value in the financial statements on a recurring basis to fiscal years beginning after November 15, 2008. The Company adopted the required provisions of SFAS No. 157-1 effective January 1, 2008 and there was no material effect on its consolidated financial statements. On January 1, 2009, the Company

19


Table of Contents

adopted FSP 157-2 and it did not have a material impact on its consolidated financial statements.  In October 2008, the FASB issued FSP 157-3, “Determining the Fair Value of a Financial Asset in a Market That Is Not Active.” The FSP was effective upon issuance, including periods for which financial statements have not been issued. The FSP clarified the application of SFAS 157 in an inactive market and provided an illustrative example to demonstrate how the fair value of a financial asset is determined when the market for that financial asset is inactive. The adoption of this FSP FAS 157-3 did not have a material impact on the Company’s consolidated financial statements.
     In April 2008, the FASB issued FASB Staff Position No. FAS 142-3, Determination of the Useful Life of Intangible Assets (“FSP No. FAS 142-3”). FSP No. FAS 142-3 requires companies estimating the useful life of a recognized intangible asset to consider their historical experience in renewing or extending similar arrangements or, in the absence of historical experience, to consider assumptions that market participants would use about renewal or extension as adjusted for SFAS No. 142’s, Goodwill and Other Intangible Assets, entity-specific factors.  FSP No. FAS 142-3 is effective for fiscal years beginning after December 15, 2008.  The Company adopted FSP No. FAS 142-3 on January 1, 2009.  The adoption of FSP No. FAS 142-3 did not have a material effect on its consolidated financial statements.
     In May 2008, the FASB issued Statement of Financial Accounting Standards (“SFAS”) No. 162, “The Hierarchy of Generally Accepted Accounting Principles.”  SFAS No. 162 identifies the sources of accounting principles and the framework for selecting the principles used in the preparation of financial statements that are presented in conformity with generally accepted accounting principles.  SFAS No. 162 becomes effective 60 days following the SEC’s approval of the Public Company Accounting Oversight Board amendments to AU Section 411, “The Meaning of Present Fairly in Conformity With Generally Accepted Accounting Principles.”  The Company does not expect that the adoption of SFAS No. 162 to have a material effect on its consolidated financial statements.
     On January 1, 2009, the Company adopted FASB No. 141 (Revised 2007), “Business Combinations” (“FAS No. 141(R)”).  FAS No. 141(R) significantly changed the accounting for business combinations. Under FAS No. 141(R), an acquiring entity is required to recognize all the assets acquired and all the liabilities assumed in a transaction at the acquisition-date fair value with limited exceptions. Transaction costs are no longer included in the measurement of the business acquired. Instead, these costs are expensed as they are incurred. FAS No. 141(R) also includes a substantial number of new disclosure requirements. FAS No. 141(R) applies to business combinations for which the acquisition date is on or after the beginning of the first annual reporting period beginning on or after December 15, 2008. The adoption of FAS No. 141(R) did not have a material impact on the Company’s consolidated financial statements.
ITEM 3. Quantitative and Qualitative Disclosures About Market Risk
     The Company is exposed to market risk from fluctuations in interest rates on cash and cash equivalents. As of March 31, 2009, the Company had $311.5 million of cash and cash equivalents. A 100 basis point decrease in interest rates would result in $3.1 million of lower annual interest income, assuming the same level of cash and cash equivalents.
     The Company is exposed to risk from fluctuations in foreign currency exchange rates. Since a substantial portion of the Company’s operations and revenue occur outside of the United States, and in currencies other than the U.S. dollar, the Company’s results can be significantly affected by changes in foreign currency exchange rates. Additionally, these changes can significantly affect intercompany balances that are denominated in different currencies. Were the foreign currency exchange rates to depreciate immediately and uniformly against the U.S. dollar by 10 percent from levels at March 31, 2009, the reported cash balance would decrease $11.9 million from a reported cash balance of $311.5 million at March 31, 2009.
ITEM 4. Controls and Procedures
     Disclosure Controls and Procedures. SPSS maintains disclosure controls and procedures that have been designed to ensure that information related to the Company is recorded, processed, summarized and reported on a timely basis. The Company’s Chief Executive Officer and Chief Financial Officer, with the participation of the Company’s Disclosure Committee, evaluated the effectiveness of the design and operation of the Company’s disclosure controls and procedures as of the end of the period covered by this report, as required by Rule 13a-15 of the Securities Exchange Act of 1934. Based on this evaluation, our Chief Executive Officer and Chief Financial Officer concluded that as of the end of the period covered by this report, the Company’s disclosure controls and procedures were effective in ensuring that the information required to be disclosed by the Company in the reports it files or submits under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC.

20


Table of Contents

     Changes in Internal Control Over Financial Reporting. There has been no change in the Company’s internal control over financial reporting that occurred during the Company’s fiscal quarter ended March 31, 2009 that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.

21


Table of Contents

PART II — OTHER INFORMATION
Item 1. Legal Proceedings
     On January 3, 2008, the Company filed a complaint for declaratory judgment in the U.S. District Court for the Northern District of Illinois against Norman H. Nie and C. Hadlai Hull. The filing of the complaint was in response to recent assertions by Dr. Nie that the Company’s use of the SPSS trademark was subject to a License Agreement (the “Agreement”) dated September 30, 1976 between a predecessor of the Company, as licensee, and Norman H. Nie and C. Hadlai Hull, as licensors. Dr. Nie stated his desire to enforce his alleged rights under the Agreement, which he claimed included the right to inspect and approve products sold under the SPSS trademark and to obtain other information regarding those products. The complaint seeks a declaratory judgment that Dr. Nie and Mr. Hull are estopped from enforcing any rights under the Agreement and that the Company shall be deemed to have an irrevocable, assignable and exclusive license to use the SPSS trademark.
     On January 28, 2008, Dr. Nie and Mr. Hull filed a counterclaim against the Company. The counterclaim asserts that the Company has repudiated the Agreement and that the Company’s use of the SPSS trademark is unauthorized and constitutes an infringement on their rights as owners of the trademark. The counterclaim seeks an injunction prohibiting the Company from continuing to use the SPSS trademark and an award of damages, costs and attorneys fees.
     On February 15, 2008, the Company filed its answer to the counterclaim. In its answer, the Company denies liability for trademark infringement and asserts that Dr. Nie and Mr. Hull are barred from asserting the counterclaim on several grounds, including but not limited to the doctrines of estoppel, laches and waiver.
     In May 2008, Dr. Nie filed an amended counterclaim to reflect that Mr. Hull had subsequently assigned his claims to Dr. Nie. Discovery has been completed. Each of the Company and Dr. Nie filed motions for summary judgment. Each motion for summary judgment was denied by the Court on April 2, 2009. The Court has set October 5, 2009 as the trial date.
     On April 27, 2009, Dr. Nie filed a complaint against the Company in the Court of Chancery of the State of Delaware seeking the advancement of legal fees and expenses incurred by Dr. Nie in connection with the action described above. The complaint seeks a declaration that SPSS must pay all such legal fees and expenses (both fees incurred to date and any fees to be incurred in the future), the payment of interest on all legal fees and expenses incurred by Dr. Nie to date and all legal fees and expenses incurred in connection with this action in Delaware.

22


Table of Contents

Item 6. Exhibits
             
        Incorporation
Exhibit       by Reference
Number   Description of Document   (if applicable)
 
   
10.1
  Form of Amended and Restated Change of Control Agreement.
 
   
10.2
  Amended and Restated Employment Agreement, dated as of May 1, 2009, by and between SPSS Inc. and Jack Noonan.
 
   
10.3
  Amended and Restated Employment Agreement, dated as of May 1, 2009, by and between SPSS Inc. and Raymond H. Panza.
 
   
31.1
  Certification of the Chief Executive Officer and President pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
 
   
31.2
  Certification of the Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
 
   
32.1
  Certification of the Chief Executive Officer and President pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
 
   
32.2
  Certification of the Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

23


Table of Contents

SIGNATURES
     Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
         
  SPSS Inc.
 
 
Date: May 6, 2009  By:   /s/ Jack Noonan    
    Jack Noonan   
    Chairman of the Board of Directors,
Chief Executive Officer and President 
 
 
     Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed by the undersigned, in his capacity as the principal financial officer of the Registrant.
         
     
Date: May 6, 2009  By:   /s/ Raymond H. Panza    
    Raymond H. Panza   
    Executive Vice President, Corporate
Operations, Chief Financial Officer and Secretary 
 

24


Table of Contents

         
SPSS INC.
EXHIBIT INDEX
     
EXHIBIT    
NO.   DESCRIPTION
 
   
10.1
  Form of Amended and Restated Change of Control Agreement
 
   
10.2
  Amended and Restated Employment Agreement, dated as of May 1, 2009, by and between SPSS Inc. and Jack Noonan
 
   
10.3
  Amended and Restated Employment Agreement, dated as of May 1, 2009, by and between SPSS Inc. and Raymond H. Panza
 
   
31.1
  Certification of the Chief Executive Officer and President pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
 
   
31.2
  Certification of the Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
 
   
32.1
  Certification of the Chief Executive Officer and President pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
 
   
32.2
  Certification of the Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

25